These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis. de Carvalho JF; Bonfá E; Bezerra MC; Pereira RM Clin Rheumatol; 2009 Jul; 28(7):801-5. PubMed ID: 19283329 [TBL] [Abstract][Full Text] [Related]
7. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis. Tombetti E; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bottazzi B; Bozzolo EP; Greco M; Rovere-Querini P; Baldissera E; Del Maschio A; Mantovani A; De Cobelli F; Sabbadini MG; Manfredi AA Arthritis Res Ther; 2014 Nov; 16(6):479. PubMed ID: 25394473 [TBL] [Abstract][Full Text] [Related]
8. Function of N-terminal pro-brain natriuretic peptide in Takayasu arteritis disease monitoring. Liu Q; Dang A; Chen B; Lv N; Wang X; Zheng D J Rheumatol; 2014 Aug; 41(8):1683-8. PubMed ID: 25028376 [TBL] [Abstract][Full Text] [Related]
9. Elevated chemokines concentration is associated with disease activity in Takayasu arteritis. Dong H; Zhang Y; Zou Y; Chen Y; Yue J; Liu H; Jiang X Cytokine; 2021 Jul; 143():155515. PubMed ID: 33849766 [TBL] [Abstract][Full Text] [Related]
10. Anaemia and low body mass index are associated with increased cardiovascular disease in patients with Takayasu arteritis. Liu Q; Dang A; Lv N; Wang X; Zheng D Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S16-20. PubMed ID: 26633551 [TBL] [Abstract][Full Text] [Related]
11. Vascular lesions in patient with Takayasu arteritis and massive elevated lipoprotein(a) levels. Residual involvement or premature aterosclerosis? Alarcón García JC; Rodríguez Suárez S; Muñiz Grijalvo O; García Morillo S Clin Investig Arterioscler; 2017; 29(2):98-102. PubMed ID: 28188021 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 12 in Takayasu's arteritis: plasma concentrations and relationship with disease activity. Verma DK; Tripathy NK; Verma NS; Tiwari S J Rheumatol; 2005 Dec; 32(12):2361-3. PubMed ID: 16331764 [TBL] [Abstract][Full Text] [Related]
14. Low bone density and low serum levels of soluble RANK ligand are associated with severe arterial calcification in patients with Takayasu arteritis. Bezerra MC; Calomeni GD; Caparbo VF; Gebrim ES; Rocha MS; Pereira RM Rheumatology (Oxford); 2005 Dec; 44(12):1503-6. PubMed ID: 16219645 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 Patients. Comarmond C; Biard L; Lambert M; Mekinian A; Ferfar Y; Kahn JE; Benhamou Y; Chiche L; Koskas F; Cluzel P; Hachulla E; Messas E; Resche-Rigon M; Cacoub P; Mirault T; Saadoun D; Circulation; 2017 Sep; 136(12):1114-1122. PubMed ID: 28701469 [TBL] [Abstract][Full Text] [Related]
16. Elevated antistreptolysin O titer is closely related to cardiac mitral insufficiency in untreated patients with Takayasu arteritis. Pan L; Du J; Zhu J; Qiao Z; Ren Y; Huang X; Guo S; Gao N BMC Cardiovasc Disord; 2020 Feb; 20(1):52. PubMed ID: 32013899 [TBL] [Abstract][Full Text] [Related]
17. Maternal and Neonatal Outcomes in 89 Patients with Takayasu Arteritis (TA): Comparison Before and After the TA Diagnosis. Assad AP; da Silva TF; Bonfa E; Pereira RM J Rheumatol; 2015 Oct; 42(10):1861-4. PubMed ID: 26329335 [TBL] [Abstract][Full Text] [Related]
19. Outcome of takayasu arteritis with inactive disease at diagnosis: the extent of vascular involvement as a predictor of activation. Hong S; Bae SH; Ahn SM; Lim DH; Kim YG; Lee CK; Yoo B J Rheumatol; 2015 Mar; 42(3):489-94. PubMed ID: 25512482 [TBL] [Abstract][Full Text] [Related]
20. The association of red blood cell distribution width with anemia and inflammation in patients with Takayasu arteritis. Liu Q; Dang AM; Chen BW; Lv NQ; Wang X; Zheng DY Clin Chim Acta; 2015 Jan; 438():205-9. PubMed ID: 25173627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]